Xenical (Genentech, Inc.)


Welcome to the PulseAid listing for the Xenical drug offered from Genentech, Inc.. This Intestinal Lipase Inhibitor [EPC],Lipase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genentech, Inc.
NON-PROPRIETARY NAME: orlistat
SUBSTANCE NAME: ORLISTAT
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Intestinal Lipase Inhibitor [EPC],Lipase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-12-17
END MARKETING DATE: 0000-00-00


Xenical HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXenical from Genentech, Inc.
LABELER NAME: Genentech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 120(mg/1)
START MARKETING DATE: 2010-12-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0004-0257_c34001f0-9f46-4b8b-a4b4-3e78e0f2aac5
PRODUCT NDC: 0004-0257
APPLICATION NUMBER: NDA020766

Other ORLISTAT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.Xenical
GlaxoSmithKline Consumer Healthcare Holdings (US) LLCALLI